Locus 33: SLC2A9 (4p16.1)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs938554 |
urate |
C/G |
7371 |
0.23 |
-0.035 (0.002) |
5.85·10-93 |
show |
| rs6838021 |
urate / histidine |
A/G |
7350 |
0.23 |
-0.043 (0.003) |
6.36·10-68 |
show |
| rs16868246 |
histidine |
C/G |
7355 |
0.21 |
0.010 (0.001) |
1.78·10-14 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs938554 |
| Chromosomal location | Chr4: 9,534,790 (4p16.1) |
| Gene (distance) | SLC2A9 (0) |
| Predicted causal gene | SLC2A9 |
| Gene/protein classification | - |
| Metabolite (Pathway) | urate (Purine metabolism, urate metabolism; Nucleotide) |
| Biochemical locus-metabolite relationship | SLC2A9 (GLUT9) encodes a transporter which acts on urate [18327257]. Ratio interpretation for urate/histidine: some evidence that histidine contributes to the urate pool, so histidine may serve to normalize urate levels in plasma ('normalizing') [4462579] |
| eQTL associations | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL2052034 |
| Drug information |
Compounds with low inhibitory activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

